The overarching question has been “can ASCT2 or LAT1 be effective targets for cancer therapy?” Likewise, the studies here were designed to assess whether either transporter might play a particularly important role in driving the biology of epithelial (modeling primary) and mesenchymal (modeling invasive/metastatic) cancer cells. This evidence concerns the gene LAT and cancer.